Healthcare-AI company Hippocratic AI secured $126 million in a financing round led by Avenir Growth, lifting its valuation to about $3.5 billion. The startup focuses on AI models for diagnostics and treatment-pathway tools, attracting venture capital interest despite broader market caution. Investors cited the company’s early product traction and clinical partnerships as drivers of confidence. The round highlights continued capital flow into applied AI in healthcare, even as scrutiny rises on validation and regulatory pathways for clinical deployments.